The first time I learned that Youfang medical announced the completion of RMB 50 million pre-A round of financing. This round of financing is led by Huaying investment, followed by huami technology and Anhui Guoyuan fund. The funds will be used for nmpa medical device registration certificate application, equipment production and sales, etc.
Founded in 2017, Youfang medical is a leading-edge medical device enterprise dedicated to the research and development of a new generation of CT imaging technology. The core of its technology is to optimize the data acquisition mode through flexible imaging algorithm design, improve product performance, reduce production costs and comprehensively improve product cost performance. Youfang medical adopts open system technology and its core imaging algorithm design, which can be applied to different clinical CT applications. It has applied for 35 domestic patents and 2 international patents.
For the relevant situation of obtaining this round of financing, the reporter interviewed Dr. Zhu Lei, founder and CEO of Youfang medical, and analyzed the reasons why Youfang medical was favored by capital from multiple perspectives.
Master the core technology, research and development of large field of vision dental CBCT system
Oral CBCT equipment is a kind of X-ray imaging system specially designed for oral and maxillofacial characteristics. With the help of CBCT, doctors can discover and cure oral diseases and complete operations that are impossible before. It can be said that oral CBCT equipment is a revolutionary tool for dentistry.
CBCT is the abbreviation of cone beam CT, which is also called open CT because of its open design. Based on the traditional spiral CT, cone beam CT (CBCT) has been upgraded in scanning and data acquisition. Its principle is that the X-ray generator makes a ring digital projection around the projector with a low amount of rays (usually the tube current is about 10 mA). After hundreds of two-dimensional projection images are obtained, the three-dimensional images are reconstructed in the computer. Through the improvement of data acquisition method, CBCT not only improves the scanning resolution of medical images, but also reduces the radiation dose to a new level.
“Traditional CT is mainly used for accurate CT imaging of the whole body, while CBCT has the advantage of single lesion imaging.” Dr. Zhu Lei said that the dental market is one of the leading positions in the development of CBCT. Although CBCT technology has been developed for many years in China, it still lags far behind the international advanced level. Specifically, the imaging algorithm is too old and the image error is too large; Using the traditional data acquisition structure, the large view system has low cost performance; The calculation time of low-dose imaging is too long, and it only stays at the level of theoretical verification.
Wide field dental CBCT system developed by Youfang medical
In view of this, Youfang medical has developed a new generation of large vision dental CBCT system. In terms of technical advantages, the global original parallel scanning technology and low redundancy reconstruction technology have made the radiation dose reduction up to 75%, breaking through the cost barrier of the existing CBCT imaging technology. The imaging resolution reaches the industry’s top 28lp / cm (national standard is 10lp / cm), In one case, the reconstruction time of CBCT with large field of view was reduced from more than 60 seconds of the current mainstream products to 2.6 seconds. Low cost, high precision, micro dose, fast reconstruction, the accumulation of medical technology, directly hit the pain point of dental CT market.
Flexible imaging algorithm design can be extended to multiple CBCT fields
According to the white paper on stomatology in 2020 issued by eggshell Research Institute, China’s total population increased from 1.34 billion in 2010 to 1.39 billion in 2017. With the growth of population base, the number of people in need of Stomatology also increased to 694 million.
On the whole, about 50% of Chinese residents suffer from various kinds of oral diseases, and the demand has remained high for a long time. However, according to the severity of the disease, most of the oral patients have not attracted enough attention. There are still a large number of residents who may not have oral disease diagnosis and treatment for various reasons, and the oral medical consumption market still has a lot of room for growth.
The new market and product iteration space will become the market opportunity of well-organized medical treatment. This is due to the flexible core imaging algorithm design technology of square medicine, which can customize different imaging algorithms according to different types of CBCT. This means that according to the algorithm system, effective medicine can adapt to the needs of different devices, so as to extend to multiple CBCT fields, including breast specific CBCT, radiotherapy assisted CBCT, mobile CBCT, etc.
As the investor of the current round, Mr. Zhou Zhenghua, vice president of Huaying investment, is full of confidence in the future of square medical treatment. He told arteria.com: “the first reason for this investment in square medical treatment is that Dr. Zhu Lei’s team is very hard core. They have very strong ability and accumulation in the key technologies of CBCT research and development, and the team structure is very complete and the executive force is strong; Second, from the market level, CBCT conforms to the trend of CT toward miniaturization and specialization, and has a very good prospect. “
Founded in April 2016, Huaying investment is a private fund manager registered with China Securities Investment Fund Association. Currently, it operates and manages two phases of funds, with a total scale of nearly 700 million yuan. Adhering to the principle of “thinking like an entrepreneur”, Huaying investment is mainly engaged in venture capital services. Members of the management team have rich experience in intelligent hardware, AI technology, Internet products and health care. Huaying investment is committed to providing services for innovative enterprises in the field of Pan Internet of things. As of the second quarter of 2020, Huaying investment’s two-phase fund has completed nearly 30 early and growth projects.
Founded in 2013, huami technology is a cloud based health service provider with the world’s leading intelligent wearable technology. Huami technology is also the first intelligent hardware innovation company in China to land on the US capital market, and was listed on the New York Stock Exchange (NYSE) in February 2018. The mission of huami technology is to “connect science and technology with health”. Through the strategy of “core cloud”, huami technology will lay out chips, intelligent wearable terminals and health cloud services, build a global health ecology, and be the most trusted partner of users. Based on the powerful artificial intelligence algorithm and big data analysis ability, huami technology provides 7×24 hour health monitoring service for users, and creates a more intelligent and convenient lifestyle for users by integrating intelligent wearable technology into the global Internet of things.
Anhui Guoyuan Fund Management Co., Ltd., with a registered capital of 100 million yuan, is an important fund management section of Guoyuan capital under Anhui Guoyuan financial holding group, entrusted to manage Anhui Guoyuan seed investment fund. Anhui Guoyuan seed investment fund, with a registered capital of 1 billion yuan, adopts the investment mode of “base + fund” and focuses on cultivating high-tech enterprises supporting seed stage and start-up stage. The fund will give full play to the guiding effect of state-owned capital, fully support the standardized operation of small and micro enterprises with scientific and technological innovation through specialized and market-oriented operation, and help enterprises in Anhui Province to innovate and grow and develop to a higher level of capital market.
Editor in charge: PJ